Sponsored by:

Molecular Imaging: Page 90

Iotron, CIIC to produce radioisotope Cu-67
By AuntMinnie.com staff writers
Iotron Medical and Canadian Isotope Innovations (CIIC) will produce the radioisotope copper-67 (Cu-67) for new cancer therapies.
August 24, 2021
2021 08 25 17 38 0178 Radiation Treatment Cancer 400
Curium files IND application for prostate PET agent
By AuntMinnie.com staff writers
Nuclear medicine firm Curium has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for its copper-64 PSMA I&T diagnostic radiopharmaceutical.
August 23, 2021
2019 04 17 20 48 2514 Prostate 3 D 400
AI helps reduce cancer PET imaging time and dose
By Will Morton
An artificial intelligence (AI) algorithm that significantly reduces PET imaging time and radiation dose in cancer patients is as effective as standard PET exams, according to a study in npj Digital Medicine.
August 23, 2021
2021 08 24 00 44 6523 2021 08 24 Ai Low Dose Pet 20210824001901
Lightpoint, Telix ink collaboration agreement
By AuntMinnie.com staff writers
Luminescence imaging technology developer Lightpoint Medical has signed a collaboration agreement with radiopharmaceutical developer Telix Pharmaceuticals.
August 22, 2021
2020 07 28 23 23 5650 Business Hands Cooperation 400
PET radiomics predict relapse in lymphoma patients
By Will Morton
There's more to F-18 FDG PET than meets the eye -- especially if radiomics features are added -- when imaging patients with diffuse large B-cell lymphoma, according to a study published August 18 in the European Journal of Nuclear Medicine and Molecular Imaging.
August 22, 2021
2021 08 19 21 20 4020 2021 08 20 Radiomics Cancer Image 20210819210552
Telix works with Merck on cancer therapies
By AuntMinnie.com staff writers
Telix Pharmaceuticals is entering into a collaboration with Merck for research studies on the combination of Merck's DNA damage response inhibitor molecules with Telix's therapeutic radiotracers.
August 19, 2021
2019 11 11 22 17 5854 Arrows Join Partner 400
Tau PET best for imaging Alzheimer's disease progression
By Will Morton
PET radiotracers that detect tau are more effective than those that target beta amyloid for predicting future cognitive decline in older patients with Alzheimer's disease, according to a study published August 12 in Alzheimer's Research and Therapy.
August 18, 2021
2020 02 26 21 58 9112 Alzheimers Tau Tangles 400
AuntMinnie.com Molecular Imaging Insider
By Will Morton
August 17, 2021
New SPECT tracer detects aggressive breast cancer
By Will Morton
A new SPECT tracer based on technetium-99m is safe in patients and can detect metastatic breast cancer -- in a few cases, better than biopsies can, according to a study published August 12 in the Journal of Nuclear Medicine.
August 15, 2021
2021 08 13 22 35 5631 2021 08 16 Spect Tracer Graphical Abstract 400
PET recommended over bone scintigraphy in pediatric sarcoma
By Will Morton
PET imaging is more effective than bone scintigraphy for detecting metastatic disease in children with soft-tissue cancer, according to a study published online August 9 in the European Journal of Cancer.
August 12, 2021
2016 09 27 14 38 54 774 Diverse Children 400
FDG-PET/CT predicts severity of COVID-19 infection
By Will Morton
FDG-PET/CT imaging in patients diagnosed with COVID-19 is associated with a higher risk of symptomatic infection and hospitalization, which may help predict disease severity, according to a study published August 8 in Clinical Imaging.
August 10, 2021
2021 08 10 23 24 4063 2021 08 11 Fdg Cancer Covid 19 20210810231936
Q BioMed signs Canadian distributor for Strontium89
By AuntMinnie.com staff writers
Biotech company Q BioMed has signed an exclusive distribution agreement for its Strontium89 therapeutic radiopharmaceutical with Canadian distributor isoSolutions Marketing & Management.
August 9, 2021
2020 02 13 23 07 2752 Q Bio Med Strontium89 400
Previous Page
Page 90 of 614
Next Page